This federal contract award, with ID SPE2DB24D8003|SPE2DB25FJTKA, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,461.18 firm fixed-price delivery order is for the supply of Vyvanse 30 mg capsules.
The award is not set-aside and is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC, which is part of the DLA Troop Support Medical's ECAT Generation V Program, allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The IDC has a performance period extending through December 31, 2025.
Generated 3/6/25, 9:43 AM